|
|
Misoprostol1. Horn, F., Weare, J., Beukers, M. W., Horsch, S., Bairoch, A., Chen, W., Edvardsen, O., Campagne, F. & Vriend, G. 1998 ; Nucleic Acids Res. 26, 275279. 2. Wilson, S. & Bergsma, D. 2000 ; Drug Des. Discovery 17, 105114. 3. Sautel, M. & Milligan, G. 2000 ; Curr. Med. Chem. 7, 889896. 4. Schoneberg, T., Schulz, A. & Gudermann, T. 2002 ; Rev. Physiol. Biochem. Pharmacol. 144, 143227. 5. Rattner, A., Sun, H. & Nathans, J. 1999 ; Annu. Rev. Genet. 33, 89131. 6. Klabunde, T. & Hessler, G. 2002 ; ChemBioChem 3, 928944. 7. Rodrigues, A. D. & Lin, J. H. 2001 ; Curr. Opin. Chem. Biol. 5, 396401. 8. Bajorath, J. 2002 ; Nat. Rev. Drug Discov. 1, 882894. 9. Jenkins, J. L., Kao, R. Y. & Shapiro, R. 2003 ; Proteins 50, 8193. 10. van Dongen, M. J., Uppenberg, J., Svensson, S., Lundback, T., Akerud, T., Wikstrom, M. & Schultz, J. 2002 ; J. Am. Chem. Soc. 124, 1187411880. 11. Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. 2000 ; Science 289, 739745. 12. Veber, D. F. 1992 ; in Peptides, Chemistry, and Biology: Proceedings of the 12th American Peptide Symposium, eds. Smith, J. A. & Rivier, J. E. ESCOM, Leiden, The Netherlands ; , pp. 314. 13. Flohr, S., Kurz, M., Kostenis, E., Brkovich, A., Fournier, A. & Klabunde, T. 2002 ; J. Med. Chem. 45, 17991805. 14. Becker, O. M., Shacham, S., Marantz, Y. & Noiman, S. 2003 ; Curr. Opin. Drug Discov. Devel. 6, 353361. 15. Pebay-Peyroula, E., Rummel, G., Rosenbusch, J. P. & Landau, E. M. 1997 ; Science 277, 16761681. 16. Luecke, H., Schobert, B., Richter, H. T., Cartailler, J. P. & Lanyi, J. K. 1999 ; J. Mol. Biol. 291, 899911. 17. Bissantz, C., Bernard, P., Hibert, M. & Rognan, D. 2003 ; Proteins 50, 525. 18. Varady, J., Wu, X., Fang, X., Min, J., Hu, Z., Levant, B. & Wang, S. 2003 ; J. Med. Chem. 46, 43774392. 19. Becker, O. M., Shacham, S., Topf, M. & Naor, Z. 2000 ; World Patent WO-02 15106-A2. 20. Shacham, S., Topf, M., Avisar, N., Glazer, F., Marantz, Y., Bar-Haim, S., Noiman, S., Naor, Z. & Becker, O. M. 2001 ; Med. Res. Rev. 21, 472483. 21. Shacham, S., Marantz, Y., Bar-Haim, S., Kalid, O., Warshaviak, D., Avisar, N., Inbal, B., Heifetz, A., Fichman, M., Topf, M., et al. 2004 ; Proteins, in press. 22. Herzyk, P. & Hubbard, R. E. 1993 ; Proteins 17, 310324. 23. Ponder, J. W. & Richards, F. M. 1987 ; J. Mol. Biol. 193, 775791. 24. Mirzadegan, T., Benko, G., Filipek, S. & Palczewski, K., 2003 ; Biochemistry 42, 27592767. 25. Miyazawa, S. & Jernigan, R. L. 1996 ; J. Mol. Biol. 256, 623644. Saturated fatty acid, heart development, phosphatidylcholine, phosphatidylethanolamine, phospholipid, pregnancy, protein, protein restriction, unsaturated fatty acid, 433 scleroderma, premature ovarian failure, uterus prolapse, 691 scoring system, pregnancy rate, reproductive success, 656 screening test, biochemical marker, endothelium lesion, oxidative stress, placenta circulation, preeclampsia, 453 second trimester abortion, fetus malformation, fetus monitoring, induced abortion, 404 second trimester pregnancy, anthropometric parameters, Down syndrome, facial bone, ultrasound, 424 - chorionic gonadotropin beta subunit, Doppler echography, first trimester pregnancy, pregnancy associated plasma protein A, pregnancy complication, uterine artery, 498 selective estrogen receptor modulator, bisphosphonic acid derivative, calcitonin, osteoporosis, 541 self esteem, clinical feature, life satisfaction, menopause, physical activity, 566 sepsis, pregnancy, 489 serology, chickenpox, pregnancy, 499 seroprevalence, cytomegalovirus infection, immunoglobulin G antibody, 529 sex differentiation disorder, chromosome 9p, chromosome deletion, prenatal diagnosis, 429 sex hormone, breast carcinoma, hormonal carcinogenesis, ovary carcinoma, uterus carcinoma, 679 sex hormone determination, alcohol, alcohol consumption, estradiol, testosterone, third trimester pregnancy, 547 sexual behavior, Human immunodeficiency virus infection, substance abuse, 706 sexual function, cystectomy, cystitis, radiation injury, urothelium, 650 single nucleotide polymorphism, endometriosis, estrogen, 654 skin allograft, graft dysfunction, vagina reconstruction, 613 sodium chloride, misoprostol, therapeutic abortion, 398 somatomedin binding protein 1, C peptide, first trimester pregnancy, pregnancy diabetes mellitus, somatomedin C, 514 somatomedin C, C peptide, first trimester pregnancy, pregnancy diabetes mellitus, somatomedin binding protein 1, 514 - epidermal growth factor, fibroblast growth factor, platelet derived growth factor, transforming growth factor beta, umbilical cord, 443 sphingosylphosphorylcholine, cyclic AMP, G protein coupled receptor, inositol phosphate, ovary cancer, 692 Section 10 vol 89.2. Although some protocols have instructed women to moisten the misoprostol before insertion, subsequent research has shown that this practice does not statistically improve efficacy. More importantly, only 17% of the respondents believe that innovation is a key asset of Indian drug companies. With laws changing in their home market and the global generic business becoming tougher, Indian companies will have to become more innovative. "For 35 years, Indian companies were doing reverse engineering, but in terms of drug discovery, nothing happened, " says Shahani. Now many Indian companies have local research centers, but that is inadequate, at least in the short run, because drug research and discovery have a high failure rate, for instance, misoprostol postpartum. Obstetric bleeding: misoprostol. Without intervention, a woman with severe postpartum hemorrhage can bleed to death in three to four hours. The blood gushes out, "like cutting an artery" -- a terrifying situation for the woman, and for any health practitioner, said Potts, a Cambridge-trained obstetrician and the Bixby professor on Population and Family Planning at the University of California at Berkeley's School of Public Health. Developed in the 1980s to prevent gastric ulcers, misoprostol is a hormone-like drug that stops the secretion of stomach acid. An Egyptian obstetrician working in London, Dr. Hazem El-Refaey, posited that the drug could work similarly on the uterus, making the muscle tissue contract, which stems bleeding. "It is low cost, heat stable, could be given orally, rectally, vaginally. A dream product, " said Potts. "If you give a dose rectally and put your hand on the uterus after delivery, you can feel it contract within a minute or two." When asked if the drug might have saved the life of the village teenager, Nana nodded. "If had, not die." So why isn't this drug in the satchel of every birth attendant in the world? Because misoprostol is also a cheap, easy-to-use, safe and effective drug that can induce abortion. "Governments are reluctant to approve this drug because they are afraid people will use it to do abortions, " said Campbell, a political scientist and health policy expert who lectures at Berkeley's School of Public Health. While misoprostol is registered worldwide as an ulcer drug, many countries -- including Thailand and Brazil -- have heavy restrictions on it because of its use in inducing abortions. In Burma and most of Africa, the drug is not available, except, perhaps, on the black market for prices out of most women's reach. Potts and Campbell, who are part of a growing cadre in women's health who see misoprostol as a miracle drug for the developing world, are working country by country to take it out of the political realm. "Countries have made abortion illegal, and we've got to deal with that. But one of the things women use for an abortion is a rib of an umbrella or a bicycle spoke, and we don't make umbrellas or bicycles illegal, " said Potts. "I think it's immoral not to save women's lives when they are dying from postpartum hemorrhage simply because they might use a drug ; for abortion." The proselytizers Potts and Campbell, husband and wife as well as colleagues, are too genteel to see themselves as drug pushers. But get them talking about misoprostol, about women's health, and it's hard to get them to stop. Campbell headed the Packard Foundation's population program in the 1990s and co-founded UC Berkeley's Center for Entrepreneurship in Health and Development. An energetic 65-year-old, she is likely to invite anyone interested in misoprostol by the office for a chat. Potts, 71, teaches classes on contraception, AIDS prevention, international health and violence, and has amassed an impressive -- and often controversial -- array of accomplishments in women's health. In 1965, he opened one of England's first clinics offering contraception to unmarried women. He was the first medical director of the International Planned Parenthood Federation, from 1968-1980. He, along. 71 ; UNIVERSITY OF M ISSISSIPPI MEDICAL CENTER [US US]; 1009 NCNPR Box 1848, University Mississippi 38677 US ; . 72 ; ELSOHLY, Mahm oud, A.; 708 Quiet Valley Cove, Oxford, MS 38655 US ; . ROSS, Sam ir. A.; 500 Wedgewood Drive, Oxford, MI 38655 US ; . 74 ; UCIDLO, Eugene, C.; Greenberg Traurig LLP, 885 Third Avenue, New York, NY 10022 US ; . 81 ; ZW. 84 ; AP GH A61K 11 ; W O 061564 21 ; PCT US02 40718 22 ; 20 Dec dc 2002 20.12.2002 ; 25 ; en 30 ; 341, 815 ; 60 343, 185 ; en 21 Dec dc 2001 21.12.2001 ; 31 Dec dc 2001 31.12.2001 ; US US 13 and calcitriol. Gynaecology research today home view latest issue information about gynaecology books on gynaecology view other research today publications introduction of the dilation and evacuation procedure for second-trimester abortion in vietnam using manual vacuum aspiration and buccal misoprostol. Blinding Double-blinding implied making placebo vials identical to oxytocin vials for women assigned misoprostol and placebo tablets identical to misoprostol tablets for women assigned oxytocin. A drug company preparing vials with 10 IU of oxytocin also prepared identical placebo vials. Another drug company prepared misoprostol 200 mcg and identical placebo tablets. In the oxytocin group, the vial contained 10 IU of oxytocin and the tablets were placebo. In the misoprostol group, the vial contained placebo liquid and the tablets contained 200 mcg of misoprostol each. The treatment packs were thus identical in shape, colour, weight and feel. The participants, those administering the interventions and those assessing the outcomes were all blinded to the group assignments. The schedule of group assignments was kept in Geneva blinded from the trial co-ordinators. Unblinding for medical reasons was possible by requesting the trial co-ordinator in Geneva to reveal the code, but there were no such cases. Evaluation of Ascertainment Bias Due to Unblinding by a Side-Effect Oxytocin alone when used in the management of the third stage of labour is relatively free of side-effects, although it carries the discomfort of injection. Ergot preparations, alone or in combination with oxytocin, cause significant rise in blood pressure, but oxytocin alone is not hypertensive. On the other hand, an association between misoprostol and shivering and other prostaglandin-related side effects i.e. nausea, vomiting, diarrhoea ; after administration has been reported. [8 12]. Some degree of unblinding could, therefore, have occurred due to the knowledge of differential side-effects. If shivering, the most prevalent of the side-effects, starts before blood loss measurement is completed, the chance of the assessor correctly guessing the treatment assignment could have been more than the 50% expected by chance in the absence of knowledge about the association. The chance of a correct guess is however unlikely to be close to 100% because shivering also occurs with delivery in a minority of women regardless of misoprostol and rocaltrol. Misoprostol brand
Induction of labour Induction of labour is a process whereby labour is started because it is felt that the baby should be delivered before waiting for spontaneous labour. There are different ways of inducing labour and this study is being done to compare different ways of administering a new drug called misoprostol. Usually the process of induction involves ripening or softening the cervix the opening of the womb ; and starting the contractions or labour pains. This is done with medicines called prostaglandins and this study compares two ways of administering a new prostaglandin by giving the first dose orally or vaginally. What is misoprostol? Mosoprostol is a prostaglandin medicine which has been used for more than 15 years for treating stomach ulcers, and has been shown to be very safe. In the last 5 years there has been lots of research using msioprostol to start or induce normal labour. A study in America in 1997 with 1500 patients showed that when it is used in low doses it is safe for the mother and baby and may lead to a shorter labour and less cesarean sections. What will happen during induction of labour? During induction of labour you will be examined vaginally every four hours and given more induction medication until the labour starts. When you receive misoprostol, a small half tablet will be given by mouth or put into the vagina. Later when the waters may be broken sometimes a drip is also needed to help with the contractions. Once the labour starts you will continue with normal labour as if you went into labour without induction, with the usual monitoring of the baby. Are there risks to being on the study? The evidence shows that misoprostol the new drug you may receive ; is safe and very effective, although the drug has not yet been formally registered. With ANY induction the baby and mother is monitored very carefully because sometimes the baby may become distressed by contractions, and will then need to be delivered by cesarean section. This can also happen even without induction of labour. Your baby's heart will be carefully monitored throughout the labour so we can detect any distress early on. Who can I ask questions about the study? The midwives and doctors on labour ward will try and answer any questions you have, and if you are still uncertain Dr. Paul le Roux or Hendrikje Lukoschus who are involved with the study will discuss the study in detail with you. Please sign the attached consent form to say you understand and agree to participate. Thanks for being on the study.
Vista, CA PRWEB ; May 3, 2007 -- Toxins exist everywhere and can lead to serious health problems. They are found in the foods consumed and the environment. Our work place may add to toxin build up from toxins floating in the air system up to extremes, such as actually working with petroleum products and chemicals. With toxins hitting us everyday, it's a must to fight back and eliminate them with a combination of diet, exercise, and by releasing toxins on a continual basis with The Detox Box. With the enhanced "hands free" option, now anytime can be the right time to detoxify. Using frequencies to support the removal of toxins that reside in the tissues of our bodies has traditionally been held to be harmless and free of side effects. A doctor's best prescription is prevention, and the best place to start is by eliminating toxins. Dr. Raymond Royal Rife theorized that specific frequencies could deactivate harmful microbes in the body without any negative side effects. In the 1930's, he discovered that each microorganism has its own frequency and can be neutralized by intensifying its specific frequency. Raymond Royal Rife invented a frequency machine, now known as a Rife Machine, aka Royal Rife Machine, the forerunner of today's "Detox Box" instrument and cefepime.
Delayed diagnosis of TB. We suggest that guidelines developed in the West may not be applicable in their entirety to other parts of the world. We hesitate to say that FQs should not be used as empiric therapy for CAP or UTI in countries with moderate to high rates of TB, but emphasise that each patient must be individually assessed and monitored. In summary, we have presented these cases in some detail not only to describe a new syndrome, brought about by the combination of new drugs and an old disease, but also to voice our concerns about the widespread empirical use of FQs in countries with moderate to high burdens of TB. REFERENCES.
Steven F. Arnold * , Michal Melamed, Daria P. Vorojeikina, Angelo C. Notides, and Shlomo Sasson Departments of Environmental Medicine and Biophysics S.F.A., D.P.V., A.C.N. ; University of Rochester School of Medicine and Dentistry Rochester, New York 14642 Department of Pharmacology M.M., S.S. ; Hebrew University of Jerusalem Faculty of Medicine, School of Pharmacy Jerusalem, 91120, Israel.
Ith instincts honed over years spent working in collapsed buildings, Mike Regan eyed the wrecked innards of the Pentagon for spaces where victims might be buried. It was Sept. 13, 2001, two days after American Airlines Flight 77 had smashed through the Pentagon's west wall. Regan led an eight-man searchand-rescue team through tangled piles of smashed office equipment. Flash fires flared around them. Finally, the team reached a charred work area. As they began to lift debris, they uncovered a conference Dan Shanower table. Then bodies. Some were still sitting in chairs. Regan approached one of them and coaxed a wallet from the trousers. There was a driver's license that belonged to Dan Shanower, 40, of Naperville, Ill. Regan noted the info on a pad and sent the wallet out to the fbi. Then Regan and his team continued searching. Keep moving, that was the ethos of the rescue squad. Focus on the work. Don't let it become personal. Yet when Regan and his wife, Janice, commemorate the fifth anniversary of the attacks next week, it will not be in Virginia, where Regan spent five days combing through the Pentagon rubble. It won't be in New York, either, even though Regan grew up in Brooklyn and lost two close friends, both firefighters, when the twin towers fell. Instead, the Regans will spend Sept. 11, 2006, in Naperville, attending a memorial service in the Chicago suburb and visiting with Dan Shanower's parents, Don and Pat. It's a connection that has grown or41.
We offer two types of abortions depending on the age of the pregnancy: surgical suction ; abortion through 13 weeks and medical abortion up to 8 weeks from the last menstrual period. Surgical Abortion Vacuum Aspiration: Induced abortion with manual handheld syringe ; aspiration is usually done from 5 through 12 weeks gestation and electrical with a suction machine through 13 weeks. The cervix will need to be gently opened, called dilation. A small straw like instrument is inserted into the uterus and then connected to suction. The procedure takes about 3 minutes. Softening of the cervix: Misoprostol tablets taken by mouth prepare the cervix for dilation by softening it and also cause the uterus to contract which decreases bleeding after the procedure. We routinely offer Misoprostol. It can cause cramping, nausea and some bleeding prior to the procedure. Anesthesia: We offer Ibuprofen Advil or Motrin ; 800 mg prior to the procedure in addition to the local numbing that is given as an injection around the cervix. Discussion Recently, misoprostol has been used by many obstetricians worldwide and has been considered as an alternative treatment for termination of pregnancy. Serious consideration should be made to use this alternative treatment instead of a standard termination of pregnancy such as dilatation & curettage. This is because the standard termination has a higher rate of infection, uterine perforation, ectopic pregnancy, anesthetic complications, and a much higher cost compared to vaginal misoprostol application. Termination of pregnancy using misoprostol is known to have a lower rate of complication and lower cost. The authors used misoprostol vaginal suppository every 6 hours for 3 consecutive doses. With a dosage of 600 g, they expected to observe a high rate of success at 24 hours and a decrease in the length of hospital stay. Moreover, the authors used misoprostol 400 g as a comparison expecting the same success rate with a lower dosage. In the present study, complete abortion was observed at a significantly higher rate with 600 g 56.9% ; compared to 400 g misoprostol 38.3% ; . The mean induction to abortion time was 8.85 + 4.68 and 9.15 + 6.09 hours, respectively. The present study showed a successful abortion rate of 81.5% when using misoprostol 600 g. However, the present study showed a lower rate of complete abortion 56.9% ; when using misoprostol 600 g compared to a higher rate of 71.66% reported by Herabutya et al 13 ; However Wong et al 15 ; reported a success rate of 60.8% observed at 24 hours using misoprostol 400 g, lower than the present study 71.7% ; . Their success rate increased to 75.7% once observation was extended for 48 hours. This is similar to the present study. The similar rate of complete abortion at 24-hours in the two studies was 41.9% and 38.3%, respectively. Kovavisarach and Sathapanachai 14 ; , studied the effectiveness of vaginal misoprostol 400 g with only one dose in patients with a gestational age of less. Where to buy misoprostol
Buy misoprostol suppositorySubarachnoid hemorrhage pregnancy, chromosomes 5 and 6, torture 2 online, meridia no prescription and cryoglobulinemia disease treatment. Buy coq10 100mg, transfusion fever, levora portia and zithromax korvatulehdus or dendritic tissue. Misoprostol y embarazoMisoprostol brand, misoprostol 2nd trimester, price of mifepristone and misoprostol, buy misoprostol and mifepristone and where to buy misoprostol. Buy misoprostol suppository, misoprostol y embarazo, misoprostol missed abortion and diclofenac misoprostol sodium or mifepristone with misoprostol methotrexate with misoprostol.
© 2009 |